About the Company
We do not have any company description for Salarius Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SLRX News
Salarius Pharmaceuticals Inc SLRX
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
Dada Nexus shares gained 0.9% to $2.33 in after-hours trading. Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) posted a net ...
Salarius: Q4 Earnings Snapshot
HOUSTON (AP) — HOUSTON (AP) — Salarius Pharmaceuticals, Inc. (SLRX) on Friday reported a loss of $882,000 in its fourth quarter. The Houston-based company said it had a loss of 22 cents per share.
Salarius Pharmaceuticals Inc (FP1.MU)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Salarius Pharmaceuticals, Inc. (SLRX)
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
Salarius Pharmaceuticals Inc SLRX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Salarius Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...